ReviewAlzheimer's & dementia (New York, N. Y.)2022
Alzheimer's disease drug development pipeline: 2022.
Jeffrey Cummings et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
285 papers cite itlatest 60 shown
this paperpooled ittrialcites it